CLINICAL_TRIALS
trial_result
· 2012-06-15
Clinical Trial Update: Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD) [Phase 1, Phase 2]
Summary
A long-term study of Metazym in patients with late infantile metachromatic leukodystrophy completed with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Late Infantile Metachromatic Leukodystrophy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-06-15